Vir Biotechnology (VIR) Non Operating Income (2018 - 2026)

Vir Biotechnology has reported Non Operating Income for 9 years, with the latest figure at $6.8 million in Q1 2026.

• Quarterly Non Operating Income fell 63.63% year-over-year to $6.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $29.7 million (down 56.01% YoY) and the FY2025 annual result came in at $41.6 million, down 35.13% from the prior year.
• Non Operating Income climbed to $6.8 million in Q1 2026 per VIR's latest filing, from $4.9 million in the prior quarter.
• Over five years, Non Operating Income peaked at $22.8 million in Q3 2022 and troughed at -$91.9 million in Q1 2022.
• A 5-year average of $5.3 million and a median of $12.5 million in 2024 frame the typical range for Non Operating Income.
• The sharpest annual moves came in 2022 and 2024: Non Operating Income tumbled 1101.06% in 2022, then soared 8140.98% in 2024.
• Over 5 years, Non Operating Income stood at -$1.1 million in 2022, then soared by 1707.31% to $18.3 million in 2023, then tumbled by 31.68% to $12.5 million in 2024, then slumped by 61.03% to $4.9 million in 2025, then jumped by 39.17% to $6.8 million in 2026.
• According to Business Quant data, Non Operating Income over the past three periods registered $6.8 million, $4.9 million, and $10.5 million for Q1 2026, Q4 2025, and Q3 2025 respectively.